These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1277066)

  • 1. Dosage, compliance and bioavailability in perspective.
    Biron P
    Can Med Assoc J; 1976 Jul; 115(2):102-3. PubMed ID: 1277066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

  • 7. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Professional development. Medicines. 2. Administration of medicines.
    Shepherd M
    Nurs Times; 2002 Apr 16-22; 98(16):45-8. PubMed ID: 11997998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bioavailability and its significance in pharmacotherapy].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assurance of drug quality (bioavailability).
    Coleman JH; Straughn AB
    Dis Nerv Syst; 1975 Feb; 36(2):63-4. PubMed ID: 1116416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bioavailability, a pseudoproblem?].
    Biron P
    Union Med Can; 1978 Dec; 107(12):1179-83. PubMed ID: 715944
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of drug concentrations in body fluids; possibilities and limitations. I. Determination of plasma levels as a basis for understanding].
    Ariëns EJ; Simonis AM
    Ned Tijdschr Geneeskd; 1980 Jul; 124(29):1192-201. PubMed ID: 6997756
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 19. Some factors affecting bioavailability of drug products.
    Lach JL
    J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.